14 employees
CrannMed is developing resorbable embolic particles and a custom delivery catheter for the treatment of Knee Osteoarthritis.
2018
$45K
from 1 investors over 1 rounds
CrannMed raised $45K on June 2, 2020
Investors: EIT Health